Enfusion's MiFID II Solution
CHICAGO, Jan. 24, 2018 /PRNewswire/ -- Enfusion, a leading provider of innovative, cloud-based investment management software and outsourced fund services, has established relationships with four leading Approved Reporting Mechanisms (ARMs) to automate transaction reporting required under the European Union's Markets in Financial Instruments Directive II (MiFID II).
Utilizing two-way workflows, Enfusion has integrated the ARMs into its Integráta platform, streamlining the transmission and validation of transaction reports.
"The biggest challenge for companies affected by MiFID II is facilitating the newly imposed reporting requirements. The granularity and precision of trading data required for MiFID II reporting can be a challenge depending on a client's source for this information," said Enfusion President, Jason Morris. "Thus, as a market leader in trading technology, we wanted to simplify and automate the process of reporting as much as possible for clients and have been working with leading ARMs to provide the best possible solutions."
Enfusion's market leading solution, Integráta, is recognized as one of the most intuitive and reliable investment management platforms in the industry. Featuring multi-asset class solutions for front, middle, and back office on a single data set, Integráta provides managers with real-time transparency and seamless process optimization.
Contact:
Interdependence Public Relations
Jacob Cohen
Account Executive
(847) 338-4813
189300@email4pr.com
About ENFUSION
For more than 10 years, Enfusion has provided technology innovation and support to the global investment management industry. Our market leading solution, Integráta, automates and simplifies investment management on a single platform and seamlessly provides asset managers full front-to-back office functionality across all asset classes. We also offer ancillary middle-and-back office fund services used by managers to streamline operations and reduce over-head expenses. As a strategic partner to over 300 top-tier firms worldwide, our clients manage more than $500+ billion in the hedge fund, institutional investment and wealth management industries. Enfusion is headquartered in Chicago, with offices in New York, London, Dublin and Hong Kong.
For more information, please contact sales@enfusionsystems.com or visit www.enfusionsystems.com
Follow us on Twitter @EnfusionSystems and LinkedIn
View original content:http://www.prnewswire.com/news-releases/enfusions-mifid-ii-solution-300587237.html
SOURCE Enfusion
